CD69 and neoplasm: One study demonstrated that tumor DNA priming immunization followed by an intranasal live-attenuated influenza boost can reprogram TCM cells into CD103+CD69+ TRM cells within two days of mucosal boosting, providing robust protection against melanoma and mesothelioma lung metastases in mice [35].